Epigenomics AG (ECX.DE)

0.378 €

0.00 (0.00%)
Symbol ECX.DE
Price 0.378 €
Beta 0.000
Volume Avg. 0.01M
Market Cap -
Shares () -
52 Week Range 0.378-2.644
1y Target Est -
DCF Unlevered ECX.DE DCF ->
DCF Levered ECX.DE LDCF ->
ROE -40.41% Strong Sell
ROA -38.24% Strong Sell
Operating Margin -
Debt / Equity 36.15% Neutral
P/E -
P/B 1.78 Strong Buy


Consensus EPS

Upgrades & Downgrades

Mr. Gregory K. Hamilton
Diagnostics & Research
Frankfurt Stock Exchange

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.